Relationship between autoantibodies against glutamic acid decarboxylase, thyroglobulin/thyroid microsome and DNA topoisomerase II in the clinical manifestation of patients with type 1 diabetes mellitus in Taiwan

European Journal of Endocrinology

Volumn 142, Issue 6, 2000, Pages 577-585

  Shiau, Ming Yuh ^c   Tsai, Shih Tzer ^c   Hwang, Jaulang ^a   Wu, Chun Ying ^b   Chang, Yih Hsin ^b  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA TOPOISOMERASE (ATP HYDROLYSING); GLUTAMATE DECARBOXYLASE; THYROGLOBULIN;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TAIWAN;

EID: 0034130503     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420577     Document Type: Article

References (48)

1. Castano L & Eisenbarth G. Typt I diabetes: a chronic-autoimmune disease of human, mouse and rat. Annual Review of Immunology 1990 8 647-679.
2. Nerup J, Mandrup-Poulsen T & Moivig J. Mechanisms of pancreatic β-cell destruction in type I diabetes. Diabetes Care 1988 11 (Suppl) 16-22.
3. Bach JF. Mechanisms of autoimmunity in insulin-dependent diabetes mellitus. Clinical and Experimental Immunology 1988 2 1-8.
4. Pujol-Borrell R, Soldevila G & Buscema M. Inappropriate expression of HLA class II molecules in endocrine epithelial cells: the phenomenon, the new experimental data and comparison with animal models. Journal of Autoimmunity 1989 2 (Suppl 2) 163-169.
5. Rossini AA, Mordes JP & Greiner DL. The pathogenesis of autoimmune diabetes. Current Opinion in Immunology 1989-1990 2 598-603.
6. Baekkeskov S, Neilsen JH & Marner B. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982 298 167-169.
7. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Cascalho M. Folli F et al. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990 347 151-156.
8. Bottazzo GF, Florin-Christensen A & Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974 2 1279-1283.
9. MacCuish AC, Barnes EW, Irvine WJ & Duncan LJP. Antibodies to pancreatic islet cells in insulin-dependent diabetics with co-existent autoimmune disease. Lancet 1974 2 1529-1531.
10. Palmer JP, Asplin CM & Clemons P. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983 222 1337-1339.
11. Pietropaolo M, Castano L, Babu S, Buelow R, Kuo YL, Martin S et al. Islet cell autoantigen 69 kD (ICA69): molecular cloning and characterization of a novel diabetes-associated autoantigen. Journal of Clinical Investigation 1993 92 359-571.
12. Castano L, Russo E, Zhou L, Lipes MA & Eisenbarth GS. Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. Journal of Clinical Endocrinology and Metabolism 1991 73 1197-1201.
13. Jones DB, Junter NR & Duff GW. Heat-shock protein 65 as a B-cell antigen of insulin-dependent diabetes. Lancet 1990 336 583-585.
14. Christie MR, Hollands JA, Brown TJ, Michelsen BK & Delovitch TL. Detection of pancreatic islet 64 000 M sub r autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. Journal of Clinical Investigation 1993 92 240-248.
15. Lu J, Li Q, Xie H, Chen ZJ, Borovitskaya AE, Maclaren NK et al. Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37 kDa tryptic fragment. Proceedings of the National Academy of Sciences of the USA 1996 93 2307-2311.
16. Notkins AL, Zhand B, Matsumoto Y & Lan MS. Comparison of IA-2 and IA-β and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera. Journal of Autoimmunity 1997 10 245-250.
17. Li Q, Borovitskaya AE, DeSilva MG, Wasserfall C, Maclaren NK, Notkins AL et al. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2β. Proceedings of the Association of American Physicians 1997 109 429-459.
18. Pietropaolo M, Peakman M, Pietropaolo SL, Zanone MM, Foley TP Jr, Becker DJ et al. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus. Journal of Autoimmunity 1998 11 1-10.
19. Wiest-Ladenburger U, Hartmann R, Hartmann U, Berling K, Böhm BO & Richter W. Combined analysis and single-step detection for GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Diabetes 1997 46 565-571.
20. Clare-Salzer MJ, Tobin AJ & Kaufman DL. Glutamate decarboxylase: an autoantigen in IDDM. Diabetes Care 1992 15 132-135.
21. Rowley MJ, Mackay IR, Chen Q-Y, Knowles WJ & Zimmet P, Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 1992 41 548-551.
22. Thai AC, Ng WY, Loke KY, Lee WRW, Lui KE & Cheah JS. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. Diabetologia 1997 40 1425-1450.
23. Chan SH, Thai AAC, Lin YN, Lui KF & Wee GB. Influence of gender and age at onset on the HLA association in Chinese with insulin-dependent diabetes mellitus. Human Immunology 1995 44 175-180.
24. Wang JC, DNA topoisomerases. Annual Review of Biochemistry 1985 54 665-697.
25. Sternglanz R. DNA topoisomerases. Current Opinion in Cell Biology 1989 1 533-535.
26. Austin CA & Fisher LM. DNA topoisomerases: enzymes that change the shape of DNA. Science Progress 1990 74 147-161.
27. Osheroff N, Zechiedrich EL & Gale KC. Catalytic function of DNA topoisomerase II. Bioassays 1991 13 269-273.
28. Chang YH, Hwang J, Shang HF & Tsai ST. Characterization of human DNA topoisomerase II as an autoantigen recognized by patients with IDDM. Diabetes 1996 45 408-414.
29. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetes Medicine 1994 11 299-303.
30. Tuomi T, Groop LF, Zimmet PZ, Rowley MJ, Knowles W & Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent diabetes mellitus in adults with a non-insulin-dependent onset of diabetes. Diabetes 1993 42 359-362.
31. Niskanen LK, Tuomi T, Karjalainen J, Groop LC & Uusitupa MJJ. GADab in NIDDM. Ten-year follow-up from the diagnosis. Diabetes Care 1995 18 1557-1565.
32. Seissler J, de Sonnaville JJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler UY et al. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Diabetologia 1998 41 891-897.
33. Park Y, Lee HK, Koh CS, Min H, Rowley M, Mackay IR et al. The low prevalence of immunogenetic markers in Korean adult-onset IDDM patients. Diabetes Care 1996 19 241-245.
34. Tuomi T, Zimmet P & Rowley M. Differing frequency of autoantibodies to glutamic acid decarboxylase among Koreans, Thais, and Australians with diabetes mellitus. Clinical Immunology and Immunopathology 1995 74 202-206.
35. Zimmet PZ, Rowley MJ & Mackay IR. The ethnic distribution of antibodies to glutamic acid decarboxylase: presence and levels in insulin-dependent diabetes mellitus in Europid and Asian subjects. Journal of Diabetes and its Complications 1993 7 1-7.
36. Chan JC, Yeung VT, Chow CC, Ko GT, Mackay IR, Rowley MJ et al. Pancreatic β cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus. Diabetes Research and Clinical Practice 1996 32 27-54.
37. Akasawa S, Kawasaki E, Yano M, Abiru N, Yamaguchi Y & Nagataki S. Autoantibodies to glutamic acid decarboxylase (GAD), 64 000-Mr islet cell protein (64 K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune disease in Japan. Diabetes Research and Clinical Practice 1994 24 (Suppl) S89-S93.
38. Yano M, Moriuchi R & Kawasaki E. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM). Journal of Autoimmunity 1995 8 83-96.
39. Kobayashi T, Sugimoto T, Itoh T, Kosaka K, Tanaka T, Suwa S et al. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method. Diabetes 1986 35 335-340.
40. Martino GV, Tappaz ML & Braghi S. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus. Journal of Autoimmunity 1991 4 915-923.
41. Chen QY, Rowley MJ & Byrne GC. Antibodies to glutamic acid decarboxylase in Australian children with insulin dependent diabetes mellitus and their first degree relatives. Pediatric Research 1995 34 785-790.
42. Verge CF, Howard NJ, Rowley MJ, Mackay IR, Zimmet PZ, Egan M et al. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 1994 37 1113-1120.
43. Tunbridg WNG, Evered D, Hall R, Appleton D, Brewis M, Clar F et al. The spectrum of thyroid disease in a community: the Wickham survey. Clinical Endocrinology 1977 7 481-493.
44. Fialkow PJ, Zavala C & Nielsen R. Thyroid autoimmunity: increased frequency in relatives of insulin-dependent diabetes patients. Annals of Internal Medicine 1975 83 170-176.
45. Betterle C, Zanette F, Pedini B, Presotto F, Rapp LB, Monociotti CM et al. Clinical and subclinical organ-specific autoimmune manifestations in type I (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 1990 26 431-436.
46. Munichoodappa C & Kozack GP. Diabetes mellitus and pernicious anemia. Diabetes 1990 19 719-723.
47. Beaven DW, Nelson DH, Renold AE & Thorn GW. Diabetes mellitus and Addison's disease: a case report of eight patients and a review of 55 cases in the literature. New England Journal of Medicine 1959 261 443-454.
48. Vandewalle CL, Falorni A, Svanholm S, Lernmark A, Pipeleers DG & Gorus FK. High diagnostic sensitivity glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset age 20-40 years. The Belgian Diabetes Registry, Journal of Clinical Metabolism 1995 80 846-851.